The potential association with NAION applies to patients using these medications for any indication, though the absolute risk remains small
Hypoglycemia Due to Medication Errors Instruct patients to always check the insulin label before each injection [see Warnings and Precautions (5.4)]
This article provides an overview of BPC 157, including its origins, potential uses, areas of ongoing research, possible side effects, general dosing considerations, and how it compares to other peptides
Intranasal corticosteroids versus oral H1 receptor antagonists in allergic rhinitis: systematic review of randomised controlled trials
A similar rationale may also be applicable in type 1 diabetes
Results may vary based on individual lifestyle and usage consistency